RVX — Resverlogix Income Statement
0.000.00%
Last trade - 00:00
- CA$15.09m
- CA$24.36m
2019 April 30th | 2020 April 30th | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 38.7 | 22.6 | 16 | 12.7 | 6.2 |
Operating Profit | -38.7 | -22.6 | -16 | -12.7 | -6.2 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -163 | 118 | -24.8 | -3.59 | -16.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -163 | 118 | -24.8 | -3.61 | -16.7 |
Net Income Before Extraordinary Items | |||||
Net Income | -163 | 118 | -24.8 | -3.61 | -16.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -163 | 118 | -24.8 | -3.61 | -16.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.865 | 0.536 | -0.103 | -0.011 | -0.06 |